Potential new therapies for the treatment of acute pancreatitis

Expert Opinion on Investigational Drugs

Volumn 8, Issue 7, 1999, Pages 973-982

  Denham, W ^a   Norman, J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Experimental pancreatitis; Human; Interleukin 1; Platelet activating factor; Tumour necrosis factor

Indexed keywords

ENZYME INHIBITOR; HYDROLASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LEXIPAFANT; MONOCLONAL ANTIBODY; OCTREOTIDE; RECOMBINANT INTERLEUKIN 10; SEMAPIMOD; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VE 13045;

ACUTE PANCREATITIS; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW;

EID: 0032799702     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.7.973     Document Type: Review

References (85)